13F HOLDINGS REPORT
GENERAL ATLANTIC, L.P.
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000950142-24-002199
Total Value
$3.18B
Positions
19
Other Managers
0
Confidential Omitted
No
Holdings (19)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | XP, INC | XP | 29,617,733 | $521.0M | 16.38% |
| 2 | DLOCAL | DLO | 63,906,695 | $517.0M | 16.26% |
| 3 | ALKAMI | ALKT | 17,186,985 | $489.5M | 15.39% |
| 4 | ALIGNMENT HEALTHCARE | ALHC | 60,993,323 | $477.0M | 15.00% |
| 5 | SQUARESPACE | 85225A107 | 10,611,073 | $463.0M | 14.56% |
| 6 | PHARVARIS | PHVS | 7,531,252 | $141.6M | 4.45% |
| 7 | EUROPEAN WAX CENTER | 29882P106 | 13,110,492 | $130.2M | 4.09% |
| 8 | AKERO THERAPEUTICS | 00973Y108 | 5,233,989 | $122.8M | 3.86% |
| 9 | CENTESSA PHARMACEUTICALS | CNTA | 9,681,818 | $87.4M | 2.75% |
| 10 | BLEND LABS | BLND | 19,132,440 | $45.2M | 1.42% |
| 11 | IMMUNOCORE | IMCR | 1,261,684 | $42.8M | 1.34% |
| 12 | ROYALTY PHARMA | RPRX | 1,500,000 | $39.6M | 1.24% |
| 13 | THIRD HARMONIC BIO | 88427A107 | 2,958,762 | $38.5M | 1.21% |
| 14 | RISKIFIED | RSKD | 5,324,998 | $34.0M | 1.07% |
| 15 | ACELYRIN | 00445A100 | 2,889,668 | $12.7M | 0.40% |
| 16 | OPENDOOR | OPENZ | 6,321,519 | $11.6M | 0.37% |
| 17 | WISH | LOGC | 609,616 | $3.5M | 0.11% |
| 18 | GROVE COLLABORATIVE | GROVW | 936,020 | $1.7M | 0.05% |
| 19 | ADAGENE | ADAG | 264,000 | $807,840 | 0.03% |